[Treatment of osteoporosis. Quality of life estimated without scientific or empiric basis].
Skribeland
N O
NO
D003362:Cost-Benefit Analysis; D006801:Humans; D009664:Norway; D010024:Osteoporosis / Q000188:drug therapy* / Q000191:economics / Q000517:prevention & control; D019057:Quality-Adjusted Life Years